← Back to headlines
Co-Diagnostics Aims for India TB Test Commercialization by Q3 2026
Co-Diagnostics anticipates the commercialization of its tuberculosis test in India by the third quarter of 2026, while also exploring SPAC options for its CoSara venture.
1 Apr, 06:43 — 1 Apr, 06:43
Sources
Showing 1 of 1 sources
Related Stories
IGNOU Extends Admission Deadline for ODL and Online Programmes
18m ago
AI Agents Lead to Increased Workload and Burnout for Engineers, Says Django Co-Creator
19m ago
Iran Issues 'Complete Annihilation' Warning to US, Threatens Tech Companies After Trump's Strike Threats
19m ago
Drones Used to Smuggle Contraband into British Prisons
20m ago